Foley Hoag advised Lantheus Holdings on the deal. Lantheus Holdings (Nasdaq: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions,...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Alcyone Therapeutics on the deal. Alcyone Therapeutics (Alcyone) announced the negotiation of a license and collaboration agreement with Biogen Inc. (Nasdaq: BIIB) to...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Applied Genetic Technologies Corporation (“AGTC”) on the deal. Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC”), a clinical-stage biotechnology company focused on the development...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Thermo Fisher Scientific on the deal. Thermo Fisher Scientific (NYSE: TMO), a world leader in serving science, acquired Combinati Incorporated and its digital PCR...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised HiFiBiO Therapeutics on the deal. FibroGen, Inc. (Nasdaq: FGEN) and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune...
You must be a Standard 1 Year member to access this content.
